A detailed history of Empirical Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Empirical Asset Management, LLC holds 33,529 shares of ABBV stock, worth $6.07 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
33,529
Previous 33,926 1.17%
Holding current value
$6.07 Million
Previous $5.82 Million 13.8%
% of portfolio
0.84%
Previous 0.67%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$163.84 - $199.33 $65,044 - $79,134
-397 Reduced 1.17%
33,529 $6.62 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $4.2 Million - $4.9 Million
27,131 Added 399.28%
33,926 $5.82 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $681,472 - $776,474
4,264 Added 168.47%
6,795 $1.24 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $16,512 - $18,596
120 Added 4.98%
2,531 $392,000
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $7,213 - $8,351
54 Added 2.29%
2,411 $359,000
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $132 - $164
-1 Reduced 0.04%
2,357 $317,000
Q1 2023

Apr 18, 2023

SELL
$144.61 - $166.54 $48,733 - $56,123
-337 Reduced 12.5%
2,358 $375,000
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $46,195 - $55,400
334 Added 14.15%
2,695 $435,000
Q3 2022

Oct 19, 2022

SELL
$134.21 - $153.93 $402 - $461
-3 Reduced 0.13%
2,361 $317,000
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $2,614 - $3,324
19 Added 0.81%
2,364 $362,000
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $309,493 - $383,993
2,345 New
2,345 $380,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Empirical Asset Management, LLC Portfolio

Follow Empirical Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Asset Management, LLC with notifications on news.